Impressive results for R-BAC post BTKi in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:28 4 years ago 156 Скачать Далее
Identifying the Role of R-BAC as Maintenance in MCL Targeted Oncology 0:42 5 years ago 113 Скачать Далее
SYMPATICO: Primary analysis results of ibrutinib plus venetoclax for patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:52 7 months ago 146 Скачать Далее
Ibrutinib plus obinutuzumab/venetoclax in R/R MCL: OAsIs results VJHemOnc – Video Journal of Hematology & HemOnc 1:08 5 years ago 159 Скачать Далее
Real-world results in the UK for ibrutinib at first relapsed for MCL VJHemOnc – Video Journal of Hematology & HemOnc 0:48 4 years ago 83 Скачать Далее
Pirtobrutinib for BTK inhibitor-naïve and BTK inhibitor pre-treated R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 471 Скачать Далее
Acalabrutinib monotherapy in R/R MCL: extended follow-up results VJHemOnc – Video Journal of Hematology & HemOnc 3:42 3 years ago 168 Скачать Далее
Long-term ibrutinib outcomes vs. prior regimens: pooled analysis in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:35 4 years ago 219 Скачать Далее
Retrospective Study Shows Activity With R-BAC Combination Following BTK Relapse in MCL Targeted Oncology 1:08 5 years ago 65 Скачать Далее
What’s New In Mantle Cell Lymphoma: Updates from ASCO 2024 & the EHA Hybrid Congress ExchangeCME 23:10 2 days ago No Скачать Далее
BTK inhibitors for R/R MCL: current uses and insights from the ViPOR study VJHemOnc – Video Journal of Hematology & HemOnc 2:40 1 year ago 126 Скачать Далее
Durable responses to ibrutinib and venetoclax in R/R MCL: 3-year AIM update VJHemOnc – Video Journal of Hematology & HemOnc 3:06 4 years ago 77 Скачать Далее
Efficacy of pirtobrutinib in patients with R/R MCL previously treated with a covalent BTKi VJHemOnc – Video Journal of Hematology & HemOnc 2:23 1 year ago 132 Скачать Далее
BTK Inhibitor Use Proves Beneficial in Mantle Cell Lymphoma Treatment curetoday 1:26 4 years ago 184 Скачать Далее
Venetoclax: an unmet need in R/R mantle cell lymphoma after BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 3:27 5 years ago 211 Скачать Далее
Venetoclax, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 66 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 165 Скачать Далее
Long-term follow-up of acalabrutinib in R/R mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 0:55 5 years ago 155 Скачать Далее
